Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 1.000 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.637 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.612 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.523 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.502 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.493 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.492 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.491 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.487 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.481 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.478 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.470 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.469 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.466 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.465 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.461 | |
| 4s33 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.460 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.457 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.456 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.456 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.450 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.449 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.448 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.446 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.445 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.444 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.442 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.442 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.441 |